Fecal iron quantification in a randomized controlled trial of Lactiplantibacillus plantarum ATCC 202195 in newborns in Dhaka, Bangladesh
Summary
No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.
Summarise with VIRAT Free to try with your Science Catalogs account.Abstract
BACKGROUND: Probiotics may enhance host iron bioavailability, offering a strategy to address iron deficiency. Fecal iron may be a useful noninvasive biomarker of such effects in infants. OBJECTIVE: To examine the use of fecal iron quantification in a randomized placebo-controlled trial (RCT) of neonatal administration of Lactiplantibacillus plantarum ATCC 202195 (LP202195), with or without fructooligosaccharide (FOS), in Dhaka, Bangladesh. METHODS: Fecal iron quantification using atomic absorption spectrometry (AAS) was optimized using standards and reference materials, and pilot-tested using pooled stool aliquots (n = 32) from an observational cohort of young infants in Bangladesh (aged 0-64 days). The optimized AAS assay was then applied to individual stool samples collected at 14 days of age (n = 307) in a RCT in which newborns aged 0-4 days were randomly allocated to one of five groups: placebo, 1- or 7-day regimens of LP202195, with or without FOS. Serum ferritin was measured at 2 months postnatal age (n = 251). Effects of the 1- and 7-day LP202195 regimens were estimated using linear regression and expressed as mean percent differences relative to placebo, with 95% confidence intervals (95% CI). RESULTS: The optimized AAS fecal iron assay had acceptable accuracy (91%-99%), precision (within- and between-run coefficients of variation 0.05 for all). Similarly, there were no effects of LP202195 on serum ferritin at 2 months of age (P > 0.05 for all). CONCLUSIONS: Fecal iron quantification by AAS was valid and feasibly implemented in a trial of neonatal administration of L. plantarum ATCC 202195. However, the assay is resource-intensive and may not be more informative than conventional measures of iron status when studying the effects of probiotics/synbiotics on iron bioavailability. CLINICAL TRIAL REGISTRY: ClinicalTrials.gov identifier: NCT05180201.
Fields of Study & Subjects
Infant Nutrition and Health
Probiotics and Fermented Foods
Iron Metabolism and Disorders
Publication details
- Journal / source
- Nutrition
- Volume
- 149
- Pages
- 113221–113221
- Publication date
- 28 March 2026
- Language
- EN